Physiopathology of premature ovarian failure: Facts and hypotheses;Physiopathologie de l'insuffisance ovarienne prematuree: Faits et perspectives

Medecine/Sciences

Volumn 15, Issue 2, 1999, Pages 204-211

  Vasseur, Claudine ^a   Christin Maitre, Sophie ^a   Bouchard, Philippe ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; HORMONE RECEPTOR; LUTEINIZING HORMONE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CHROMOSOME 3Q; FEMALE; GENE MUTATION; HUMAN; OVARY FOLLICLE; OVARY INSUFFICIENCY; PRIMARY AMENORRHEA; RECEPTOR GENE; SECONDARY AMENORRHEA; TURNER SYNDROME; X CHROMOSOME;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0032981796     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1312     Document Type: Article

References (51)

1. Goujeon A, Lefevre B. Folliculogenèse et maturation ovocytaire. In: Mauvais-Jarvis P, Schaison G, Touraine eds. Médecine de la reproduction. Paris: Médecine-Sciences Flammarion, 1997: 48-65.
2. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987; 65: 1231-7.
3. Letur-Kōenig H, Roaul-Duval A, Bertrand-Servais M, Olivennes F, Franchin R, Hazout A, Flis-Treves M, Selva J, Frydman R. Pratique du don d'ovocytes: l'expérience de l'hôpital Antoine-Béclère. Med Sci 1995; 11: 591-600.
4. Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R. Low temperature storage and grafting of human ovarian tissue. Hum Reprod 1996; 11: 1487-91.
5. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981; 23: 1377-82.
6. Perez GI, Knudson CM, Levkin L, Korsmeyer SJ, Tilly JL. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med 1997; 3, 11: 1228-32.
7. Damewood MD, Grochow LB. Prospects for fertility after chemotherapy or radiation for neoplasic disease. Fertil Steril 1986; 45: 443-59.
8. Stillman RJ, Schinfeld SJ, Schiff I. Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet 1981; 139: 62-6.
9. Schlumberger M, De Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE, Pinchera A, Parmentier C. Exposure to radioactive Iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996; 37: 606-2.
10. Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981; 304: 994-7.
11. Cooper GS, Baird DD, Hulka BS, Weinberg CR, Savitz DA, Hughes CL Jr. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995; 85: 407-11.
12. Hoek, A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocrinol Rev 1997; 18: 107-34.
13. Irvine WJ, Chan MMW, Scarth L, Kolb FO, Hartog M, Bayliss RIS, Drury MI. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1968; 2: 883-7.
14. Nagamine K, Peterson P, Scott H.S, et al. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393-7.
15. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 1997; 17: 399-403.
16. Winqvist O, Gebre-Medhin G, Gustafsson J, Ritzen EM, Lundkvist O, Anders Karlsson F, Kämpe O. Identification of the main gonadal autoantigens in patients with adrenal insufficiency and associated ovarian failure J Clin Endocrinol Metab 1995; 80: 1717-23.
17. Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M, Hettiarachchi S, Vergani D, Conway GS, Peakman M. Identification of 3β-hydroxysteroid deshydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81: 4439-45.
18. Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, De Cherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70: 69-75.
19. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of Follicle-Stimulating Hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982; 54: 1221-8
20. Anasti JN, Flack MR, Froehlich J, Nelson LM. The use of recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 1995; 80: 824-8.
21. Teusher C, Wardell BB, Lunceford JK, Michael SD, Tung KS. Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes whith I12, Fgfb, and Idd3. J Exp Med 1996; 183: 631-7.
22. Corenblum B, Rowe T, Taylor PJ. High-dose, short-term glucocorticoids for traitement of infertility resulting from premature ovarian failure. Fertil Steril 1993; 59: 988-91.
23. Singh RP, Carr DH. The anatomy and histology of XO human embryos and fetuses. Anat Rec 1966; 155: 369-83.
24. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995; 95: 607-29.
25. Krauss CM, Turksoy RN, Atkins L, Laughlin C, Brown LG, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987; 317: 125-31.
26. Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet 1990; 85: 455-61.
27. Sala C, Arrigo G, Torri G, et al. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb Yac contig spanning Xq21. Genomics 1997; 40: 123-31.
28. Bione S, Sala C, Manzini C, et al. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 1998; 62: 533-41.
29. Conway GS, Payne NN, Conway E, et al. A genetic study of familial and sporadic premature ovarian failure: screening for FSH mutations of the FSH receptor and ZFX genes and for FRAXA premutations. The Endocrine Society 1997, 79 th annual meeting.
30. Luoh SW, Bain PA, Polakiewick RD, Goodheart ML, Gardner H, Jaenisch R, Page DC. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997; 124: 2275-84.
31. Aittomäki K, Dieguez Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82: 959-67.
32. Layman LC, Amde S, Cohen DP, Jin M, Xie J. The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46, XX ovarian failure. Fertil Steril 1998; 69: 300-2.
33. Whitney EA, Layman LC, Chan A Lee PJ, Peak DB, McDonough PG. The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls. Fertil Steril 1995; 64: 518-24.
34. Beau I, Touraine P, Gougeon A, et al. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 1998; 102: 1352-9.
35. Latronico AC, Anastasi J, Arnhold IJP, Rapaport R, Mendonca BB, Bloise W, Castro M, Tsigos C, Chrousos GP. Testicular and ovarian resistance to luteinizing hormone caused by inactiving mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 334: 507-11.
36. Toledo SPA, Brunner HG, Kraaij R, Post M, Dahia PLM, Hayashida CY, Kremer H, Themmen APN. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX Female. J Clin Endocrinol Metab 1996; 81: 3850-4.
37. Amati P, Chomel JC, Nivelon-Chevalier A, Gilgenkrantz S, Kaplan J, Bonneau D. A gene for Bblepharophimosis-ptosisepicanthus inversus syndrome maps to chromosome 3q22-q23. Hum Genet 1995; 96: 213-5.
38. Panidis D, Rousso D, Vavilis D, Skiadopoulos S, Kalogeropoulos A familial blepharophimosis with ovarian dysfunction Hum Reprod 1994; 4: 2034-7.
39. Smith A, Fraser IS, Shearman RP, Russel P. Blepharophimosis plus ovarian failure: a likely candidate for a contiguous gene syndrome. J Med Genet 1989; 26: 434-8.
40. Miller ME, Chatten J. Ovarian changes in ataxia telegiectasia. Acta Paediatr Scand 1967; 56: 559-61.
41. Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telegiectasia. Cell 1996; 86: 159-71.
42. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A Chatterjee VKK. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nat Genet 1993; 5: 83-6.
43. Layman LC, Lee EJ, Peak DB, Namnoum AB, VU KV, Van Lingen BL, Gray MR, McDonough PG, Reindollar RH, Jameson JL. Delayed puberty and hypogonadism caused by mutations in the follicule-stimulating hormone β-subunit gene. N Engl J Med 1997; 337: 607-11.
44. Brunie S, Delage MM. Structure tridimensionnelle des gonadotrophines. In Combarnous Y, Volland-Nail, eds. Les gonadotrophines. Paris: INRA, 1997: 27-39.
45. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicule stimulating hormone is required for ovarian follicucle maturation but not for male fertility. Nat Genet 1997; 15: 201-6.
46. Yu Hsh S, Jen-May Lai R, Finegold M, Hsueh AJW. Targeted overexpression of Bcl-2 in ovaries of transgenic mice leads to decreased follicule apoptosis, enhanced folliculogenesis, and increased germ cell tumorogenis. J Clin Endocrinol Metab 1996; 137: 4837-43.
47. Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicules established in the post-natal female mouse gonad. Endocrinology 1995; 136: 3665-8.
48. Erickson GF. Defining apoptosis: players and systems. J Soc Gynecol Invest 1997; 4; 5: 219-27.
49. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature 1907; 385: 525-8.
50. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM. Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 1998; 12: 96-106.
51. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531-5.